Clinical trial
A Phase 2a Multicenter Randomized Controlled Trial Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion) Compared to Standard of Care in the Repair of Mixed Motor-sensory Acute Peripheral Nerve Injuries (PNI) for Rapid and Immediate Improvement in Outcome
NCT04789044 is registered in ClinicalTrials.gov with Major Extremity Trauma Research Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2a Multicenter Randomized Controlled Trial Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion) Compared to Standard of Care in the Repair of Mixed Motor-sensory Acute Peripheral Nerve Injuries (PNI) for Rapid and Immediate Improvement in Outcome
- Lead sponsor
- Major Extremity Trauma Research Consortium
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- June 1, 2023
- Completion date
- October 1, 2028
- Enrollment
- 40 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.